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QUANTITATIVE HISTOCHEMISTRY OF THE PRIMATE SKIN
VIII. ENOLASE
KENJI ADACHI, M.D., PH.D., AWl) SHOKO YAMASAWA, B.Sc.
Since the discovery of enolase in muscle ex-
tracts by Lohmann and Meyerhof in 1934, it
has been shown that the enzyme is present in
almost all living cells (1). Its presence in skin
was suggested by Glasenapp and Leonhardi who
found that fluoride caused a retardation of
glycolysis (2). Bernstein et al. (3) demon-
strated that 3-phosphoglyceric acid was stoichi-
ometrically converted to lactic acid with crude
extract from young rat skin. This indicated the
presence of a series of enzymes in the test sys-
tem such as phosphoglycerate mutase, enolase,
pyruvate kinase and lactate dehydrogenase.
This communication reports the direct dem-
onstration of enolase in skin and a partial char-
acterization of it.
MATERIALS AND METHODS
The materials and general analytical technics
were essentially the same as those described in a
previous paper (4). The assay method for enolase
is based on the measurement of the reaction prod-
uct, phosphoenolpyruvate. This is subsequently
converted to lactic acid with the concomitant
oxidation of NADU' on the addition of crystal-
line pyruvate kinase and lactate dehydrogenase.
Thus, the dehydrogenation of one mole of 2-
phosphoglycerate corresponds to the oxidation of
one mole of NADII, which may be measured
fluorometrically to permit high sensitivity (5).
The complete enolase assay reagent° consisted
of 3 mM 2-phosphoglycerate, Na salt; 2 mM
adenosine diphosphate; 1 mM NADH; 5 mM
MgSO; 50 mM KCI; 0.05% bovine plasma albu-
min; 5 eg/ml reagent mixture of lactate dehy-
drogenase; 10 g/ml pyruvate kinase; 0.1 M
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'Abbreviations used are: NADH and NAD =
nicotinamide adenine dinucleotide, reduced and
oxidized forms, respectively.2 chemicals were commercially available and
of reagent grade. The crystalline lactate dehydro-
genase has a specific activity of 400 /Lmoles of
pyruvate to lactate per minute per mg protein atpH 7.5 at 37° C, and the crystalline pyruvate
kinase has a specific activity of 250 imoles of phos-
phoenolpyruvate to pyruvate per mm. per mg
protein at pH 7.6 at 370 C.
dazole buffer, pH 7.1; and 5 el of the epidermal
homogenate (0.5% usually) in a total volume of
50 id. NADH oxidation was measured exactly as
described previously (6).
For the microassay of enolase activity in skin,
the reaction mixture was added to 1 ig samples
(average) and NAD formation was measured as
described previously (6).
The substrate, sodium 2-phosphoglycerate, was
prepared from barium salt by the addition of sul-
furic acid followed by neutralization with sodium
hydroxide. The substrate concentration was meas-
ured specifically by NADH-coupled reaction with
the auxiliary crystalline enzymes, i.e., enolase,
pyruvate kinase and lactate dehydrogenase. Lactic
acid was measured according to the method of
Barker and Summerson (7).
RESULTS
The optimal pH for enolase in imidazole
buffer was ordinarily found to be 7.1 (Fig. 1),
which is within physiological range. When
enolase activity was tested in Tris buffer, the
maximal activity was also obtained at a physio-
logical pH range (7.2). Tris buffer, however,
seemed to inhibit enolase activity by 10 to 30%.
The effect of the substrate is shown in Fig. 2.
The optimal concentration of 2-phosphoglycer-
ate was between 1.5 and 3 mM. A graphic anal-
ysis of apparent Michaelis constant for 2-phos-
phoglycerate with the epidermal homogenate as
enzyme source yielded approximately 5 >( 10-'
M. When one of the auxiliary enzymes, i.e.,
either pyruvate kinase or lactate dehydrogen-
ase, was omitted from the assay reagent mix-
ture, the epidermal enolase activities varied
from 70 to 95% of maximal values. Whereas
these enzymes seem to be abundantly present in
the homogenate, there is not enough endogenous
enzyme to attain optimal enolase activity. Fig-
ure 3 shows the enzyme activities with different
amounts of epidermal homogenate. A linear
rate of reaction was assessed up to nearly 30
mmoles of NAD formation per reaction ves-
sel. Similarly, a linear rate of the time course
of the reaction was observed over a wide range.
The stoichiometry of the reaction catalyzed by
the epidermal enolase was also tested. The d.is-
appearance of 2-phosphoglycerate (280 mjmoles
/ml) corresponded to that of NADH (285
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mtmoles/m1) as well as to the formation of
lactic acid (290 memoles/m1).
Since the metal ion specificity in the activa-
tion of enolase is well known (9, 10), the effects
of the addition of several divalent ions (at 3
mM final concentration) were tested. The
fluorometric assay method for enolase de-
scribed above is not applicable to the test for the
addition of magnesium ion because Mg is an
absolute requirement for the subsequent pyru-
vate kinase reaction. Therefore, enolase was
spectrophotometrically assayed as described by
Bücher (8). This optical method was originally
developed by Warburg and Christian and is
based on the absorption of phosphoenolpyruvate
at 240 m. The enzyme used was 5 t1 of super-
natant fraction of 10% epidermal homogenate
centrifuged at 1000 rpm for 5 minutes.
Magnesium ion was found to be an absolute
requirement. When the activation factor of
magnesium ion was taken as 100, that of Mn
was approximately 6, that of Zn less than 2,
2
2PGA mM
Fia. 2. Effect of 2-phosphoglycerate. The test
system as in the text except for varying amounts
of the substrate.
0 50 IOO,gg
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Fia. 3. Effect of enzyme concentration. For ex-
perimental detail, see text. The ordinate indicates
NAD formation in terms of mmoles per reaction
tube.
TABLE I
Enolase activity in various skin struclures*
Skin Structure moii Stump-matcue
SCALP
Epidermis 13.2 9.0
Hair follicle 14.6 12.4
Eccrine gland 23.2 23.4
Apocrine gland — 7.6
Sebaceous gland 6.2 9.7
Dermis 0.5 0.1
SOLE
Keratin layer 2.5 1.4
Granular layer 9.7 6.2
Prickle layer 21.0 14.5
Basal layer 27.4 18.9
Eccrine gland 28.6 13.2
Dermis 1.3 0.3
LIP
Mucous membrane, upper 9.6 9.1
Mucous membrane, lower 15.1 12.0
Sebaceous gland 5.7 8.6
* Enolase activities are expressed as moles of
the substrate, 2-phosphoglycerate, dehydrogen-
ated per kilogram of dry weight sample per hour
(moles/kg dry wt/hr). Each figure is the mean of
five determinations.
and that of Co none. The effect of the addition
of fluoride to epidermal homogenate was also
tested under the spectrophotometric assay sys-
tem. A final concentration of NaF at 1 mM
caused no apparent inhibition, but at 5 mM it
caused 80% inhibition and at 12.5 mM nearly
100% inhibition.
The activities of enolase in various parts of
the skin of the rhesus monkey and the stump-
tail macaque are summarized in Table I. Gen-
OF
, 30
(I)
0
E IC
80
60
40
20
6 7 8
PH
Fra. 1. pH activity curve. The assay system as
in the text. The enolase activity, as indicated in
the ordinate, is expressed as the microammeter
reading due to fluorescence.
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erally the enzyme activities in the cutaneous
appendages of the rhesus monkey resemble
those in the stump-tail macaque except for
those in the sole. The ecerine sweat glands ap-
pear to contain the highest activity, averaging
22 moles/kg dry wt/hour. The epidermis, mu-
cous membrane and hair follicles also have high
enolase activities ranging from 10—28 moles/kg
dry wt/hour. The sebaceous glands have rela-
tively low activity, 6—10 moles/kg dry wt/hr.
The dermis contains only negligible enolase
activity.
DISCUSSION
The regional variations of enolase activity
resemble those of pyruvate kinase or lactate
dehydrogenase. This similarity in the distribu-
tion pattern of the three enzymes is coupled
with a similarity in their catalytic characteris-
tics, such as optimal pH, optimal activities and
Km for their substrates. This suggests a close
association of these enzymes in catalytic reac-
tions in skin and it coincides with their location
in the glycolytic pathway.
The metal ion specificity in the activation of
yeast enolase has been studied in considerable de-
tail and seven divalent ions are known to act as
coenzymes in the following order: Mg > Zn >
Mn > Fe(II) > Cd> Co, Ni. Although our
crude homogenate system does not allow us to
study the precise kinetics on binding of metal
ions to the enzyme, our data on the metal acti-
vation, i.e., Mg> Mn> Zn, may be suggestive
of a similar metal-binding mechanism to acti-
vate the epidermal enolase. At any rate, Mg
requirement as coenzyme for epidermal enolase
may be regarded as a significant factor for
physiological control of this enzyme in skin and
its appendages.
SUMMARY
Enolase activity in various parts of the pri-
mate skin has been measured with a microfluoro-
metric method. Enolase has been found to be
one of the most active enzymes participating in
the glycolytic pathway. The regional distribu-
tion pattern and activity of enolase generally
resemble those of pyruvate kinase and lactate
dehydrogenase. High activities (10—28 moles/kg
dry wt/hr) are found in epithelial tissues such
as the epidermis, hair follicles and mucous
membrane, and relative low activities (6—10
moles/kg dry wt/hr) in sebaceous glands from
the lip and scalp region. The apocrine sweat
gland has medium high activity (7.6 moles/kg
dry wt/hr), however the eccrine sweat glands
contain an exceptionally high enolase activity
(an average of 22 moles/kg dry wt/hr). The
epidermal enolase has been shown to be sensi-
tive to Mg which actually acts as coenzyme.
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